Serum creatine kinase elevation as a possible complication of therapy with olanzapine.
Perlov
Evgeniy
E
Department Psychiatry and Psychotherapy, University Hospital of Freiburg, Hauptsrtasse 5, 79098, Freiburg, Germany. evgeniy_perlov@psyallg.ukl.uni-freiburg.de
Tebartz van Elst
Ludger
L
Czygan
Martin
M
Bubl
Emanuel
E
Ebert
Dieter
D
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D052283:Creatine Kinase, MM Form / Q000097:blood*; D006801:Humans; D008297:Male; D009211:Myoglobin / Q000097:blood*; D000077152:Olanzapine; D011618:Psychotic Disorders / Q000097:blood* / Q000188:drug therapy; D044465:White People
D014150:Antipsychotic Agents; D009211:Myoglobin; D001569:Benzodiazepines; D052283:Creatine Kinase, MM Form; D000077152:Olanzapine